Trials / Completed
CompletedNCT00832546
A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers
A Double-Blind, Randomized, Placebo Controlled, Cross-Over, Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- TorreyPines Therapeutics · Industry
- Sex
- Male
- Age
- 21 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the effects of NGX426 on intradermal capsaicin induced pain in hyperalgesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | |
| DRUG | Oral NGX426 (Powder in solution) |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2009-01-30
- Last updated
- 2009-01-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00832546. Inclusion in this directory is not an endorsement.